← All patents

US9551713B2

Use of a panel of urinary cytokines to predict response to BCG therapy for …

University of Texas System

Abstract

Methods for predicting cancer recurrence following a BCG immunotherapy are provided. In some aspects, cytokine levels from a patient are measured before and after a BCG therapy and the changes in cytokine levels are used to determine the risk of cancer lapse. Methods for selecting a patient for a …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Ashish M. Kamat
Priority date
March 02, 2012
Filing date
March 04, 2013
Grant date
January 24, 2017
Publication date
January 24, 2017
Language
en
Metadata fetched
August 29, 2026 00:25